Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rio

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Lancet (London, England)|August 31, 1996
Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of HaematologyG Socié, J Y Mary, A de Gramont, et al.
Presse Medicale (Paris, France : 1983)|September 3, 1994
[Veno-occlusive disease of the liver after bone marrow transplantation. Report of the symposium Autograft in France and the group of study of bone marrow transplantation. France Auto-Greffe et le Groupe d'Etude de la Greffe de Moelle osseuse]B Rio, J Y Cahn, M Attal, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 24, 1999
Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patientsJ P Marie, Z Marjanovic, A Vekhoff, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1996
Interstitial pneumonitis following autologous bone-marrow transplantation conditioned with cyclophosphamide and total-body irradiationM Ozsahin, Y Belkacémi, F Pène, et al.
Bone Marrow Transplantation|July 1, 1989
Donor bone marrow treatment with T101 Fab fragment-ricin A-chain immunotoxin prevents graft-versus-host diseaseG Laurent, D Maraninchi, E Gluckman, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1990
Bone marrow transplantation for chronic myelogenous leukemia. Results of the French Cooperative Group (GEGMO)A Devergie, J Reiffers, J P Vernant, et al.
Leukemia|July 30, 2003
Risk assessment in adult acute lymphoblastic leukaemia before early haemopoietic stem cell transplantation with a geno-identical donor: an easy clinical prognostic score to identify patients who benefit most from allogeneic haemopoietic stem cell transplantationN-C Gorin, M Labopin, E Polge, et al.
Presse Medicale (Paris, France : 1983)|November 2, 1985
[Autograft of bone marrow treated by immunotoxin T 101 for the treatment of T-cell leukemia and lymphoma. Initial clinical cases]N C Gorin, L Douay, J P Laporte, et al.
British Journal of Haematology|October 29, 2000
Feasibility and recent improvement of autologous stem cell transplantation for acute myelocytic leukaemia in patients over 60 years of age: importance of the source of stem cellsN C Gorin, M Labopin, P Pichard, et al.
Leukemia|June 1, 1993
Cyclosporin A as a modifier agent in the salvage treatment of acute leukemia (AL)J P Marie, J N Bastie, F Coloma, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Lancet (London, England)|August 31, 1996
Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of HaematologyG Socié, J Y Mary, A de Gramont, et al.
Presse Medicale (Paris, France : 1983)|September 3, 1994
[Veno-occlusive disease of the liver after bone marrow transplantation. Report of the symposium Autograft in France and the group of study of bone marrow transplantation. France Auto-Greffe et le Groupe d'Etude de la Greffe de Moelle osseuse]B Rio, J Y Cahn, M Attal, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 24, 1999
Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patientsJ P Marie, Z Marjanovic, A Vekhoff, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1996
Interstitial pneumonitis following autologous bone-marrow transplantation conditioned with cyclophosphamide and total-body irradiationM Ozsahin, Y Belkacémi, F Pène, et al.
Bone Marrow Transplantation|July 1, 1989
Donor bone marrow treatment with T101 Fab fragment-ricin A-chain immunotoxin prevents graft-versus-host diseaseG Laurent, D Maraninchi, E Gluckman, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1990
Bone marrow transplantation for chronic myelogenous leukemia. Results of the French Cooperative Group (GEGMO)A Devergie, J Reiffers, J P Vernant, et al.
Leukemia|July 30, 2003
Risk assessment in adult acute lymphoblastic leukaemia before early haemopoietic stem cell transplantation with a geno-identical donor: an easy clinical prognostic score to identify patients who benefit most from allogeneic haemopoietic stem cell transplantationN-C Gorin, M Labopin, E Polge, et al.
Presse Medicale (Paris, France : 1983)|November 2, 1985
[Autograft of bone marrow treated by immunotoxin T 101 for the treatment of T-cell leukemia and lymphoma. Initial clinical cases]N C Gorin, L Douay, J P Laporte, et al.
British Journal of Haematology|October 29, 2000
Feasibility and recent improvement of autologous stem cell transplantation for acute myelocytic leukaemia in patients over 60 years of age: importance of the source of stem cellsN C Gorin, M Labopin, P Pichard, et al.
Leukemia|June 1, 1993
Cyclosporin A as a modifier agent in the salvage treatment of acute leukemia (AL)J P Marie, J N Bastie, F Coloma, et al.
Pageof 11